SCHEMBL7673449

SCHEMBL7673449

Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)N[C@H](CC(C)C)C(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLAU P00749 2/20 0.59
HPN P05981 2/20 0.59
MMP9 P14780 4/20 0.57
LMNA P02545 2/20 0.50
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
MAPT P10636 3/20 0.48
KDM4E B2RXH2 2/20 0.48
ATM Q13315 1/20 0.48
AIMP2 Q13155 1/20 0.48
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.47
MMP2 P08253 4/20 0.46
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
MMP3 P08254 2/20 0.45
MMP13 P45452 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7674329 1.00 PLAU (0.59) PLAUHPNMMP9LMNAMEN1
SCHEMBL7673536 0.91 MMP9 (0.57) PLAUHPNMMP9LMNAMEN1
SCHEMBL7665170 0.91 MMP9 (0.57) PLAUHPNMMP9LMNAMEN1
SCHEMBL7667625 0.88 MMP9 (0.57) PLAUHPNMMP9LMNAMEN1
SCHEMBL7670593 0.86 LMNA (0.55) PLAUHPNMMP9LMNAMEN1
SCHEMBL7673629 0.85 MMP9 (0.76) PLAUHPNMMP9MAPTKDM4E
SCHEMBL5090722 0.85 MMP9 (0.76) PLAUHPNMMP9MAPTKDM4E
SCHEMBL7676199 0.85 MMP9 (0.72) PLAUHPNMMP9LMNAMEN1
SCHEMBL7667679 0.85 MMP9 (0.72) PLAUHPNMMP9LMNAMEN1
SCHEMBL7671437 0.84 MMP9 (0.59) PLAUHPNMMP9LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed